The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 25, 2022

Filed:

Mar. 17, 2021
Applicant:

Syz Cell Therapy Co., Guangdong, CN;

Inventors:

Xiangjun Zhou, Guangdong, CN;

Jin Li, Guangdong, CN;

Yanyan Han, Guandong, CN;

Dongyun Wu, Guangdong, CN;

Junyun Liu, Guangdong, CN;

Longqing Tang, Guangdong, CN;

Ran Tao, Guangdong, CN;

Assignee:

SYZ Cell Therapy Co., Shenzhen, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 45/06 (2006.01); A61K 39/00 (2006.01); C12N 5/0783 (2010.01); C12N 5/0784 (2010.01); A61K 35/17 (2015.01); A61K 35/14 (2015.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 35/14 (2013.01); A61K 35/17 (2013.01); A61K 45/06 (2013.01); C12N 5/0636 (2013.01); C12N 5/0639 (2013.01); A61K 2039/5154 (2013.01); A61K 2039/5158 (2013.01); C12N 2501/998 (2013.01); C12N 2502/1114 (2013.01); C12N 2502/1121 (2013.01);
Abstract

Provided is a method of treating a cancer in an individual using activated T cells or PBMCs induced by antigen presenting cells (such as dendritic cells) loaded with a plurality of tumor antigen peptides. The method may further comprise administration of the antigen presenting cells loaded with the plurality of tumor antigen peptides to the individual. The methods may be used singly or in combination with an immune checkpoint inhibitor. Also provided are precision therapy methods customized for the individual using neoantigen peptides or based on the mutation load in the tumor of the individual, methods of preparing the activated T cells, methods of monitoring the treatment, methods of cloning tumor-specific T cell receptors, an isolated population of cells comprising the activated T cells, and compositions and kits useful for cancer immunotherapy.


Find Patent Forward Citations

Loading…